Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 6, 2026, 3:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Aspirin - 325 mg per day + Placebo Clear all

Conditions: Ischemic Stroke, Patent Foramen Ovale
Interventions: Warfarin, Aspirin; Drug
Lead sponsor: Columbia University; Other
Eligibility: 30 Years to 85 Years
Enrollment: 630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Glioblastoma
Interventions: Aspirin, Placebo; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Peripheral Arterial Disease
Interventions: Placebo + background APT + SMT, Vorapaxar 2.08 mg/d + background APT + SMT.; Drug
Lead sponsor: North Texas Veterans Healthcare System; Federal
Eligibility: 40 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 12
States / cities: Tucson, Arizona • San Diego, California • Denver, Colorado + 8 more

Conditions: Depression, Depressive Disorder, Major Depressive Disorder, Treatment Resistant Depression
Interventions: Aspirin 325mg, Placebo Oral Tablet; Drug
Lead sponsor: Jessica Harder; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Herpes Simplex
Interventions: valacyclovir hydrochloride, placebo, valacyclovir plus aspirin; Drug
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 20 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: New Orleans, Louisiana

Conditions: Mammographic Breast Density
Interventions: Aspirin, Placebo; Drug
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 55 Years to 75 Years · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Healthy
Interventions: Acetaminophen - 4 grams per day + Placebo, Aspirin - 325 mg per day + Placebo, Acetaminophen 4 gram per day + Aspirin 325 mg per day; Drug
Lead sponsor: University of Illinois at Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Impaired Glucose Tolerance, Prediabetic State
Interventions: Aspirin, Alpha lipoic acid, Olmesartan, Placebo; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Cerebrovascular Accident, Hypertension
Interventions: aspirin, clopidogrel, Target of Blood Pressure, placebo; Drug · Other
Lead sponsor: University of British Columbia; Other
Eligibility: 30 Years and older
Enrollment: 3,020 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 39
States / cities: Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 32 more

Conditions: Healthy
Interventions: Aspirin, Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 50 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Colorectal Cancer
Interventions: aspirin, placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 30 Years to 74 Years
Enrollment: 635 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2006
U.S. locations: 41
States / cities: Scottsdale, Arizona • San Francisco, California • Miami Beach, Florida + 37 more

Conditions: Healthy Volunteers
Interventions: Aspirin, BMS-986177, Placebo; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Metabolic Syndrome
Interventions: Pioglitazone, Placebo, Niacin ER, Aspirin; Drug · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy Volunteers
Interventions: BMS-986177, Placebo (for BMS-986177), Clopidogrel, Aspirin; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Coronary Artery Disease
Interventions: Prasugrel, Clopidogrel, Placebo for Prasugrel, Placebo for Clopidogrel; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 4
States / cities: Jacksonville, Florida • Worcester, Massachusetts • Ann Arbor, Michigan + 1 more

Search by objective public record fields.

Patent Foramen Ovale in Cryptogenic Stroke Study

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Salicylic Augmentation in Depression

30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density

The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers

Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

Secondary Prevention of Small Subcortical Strokes Trial

Effect of Aspirin on Gut Microbiome

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting